Gardasil
Human papillomavirus vaccine (quadrivalent recombinant) · 20 mcg (HPV6) + 40 mcg (HPV11) + 40 mcg (HPV16) + 20 mcg (HPV18) / 0.5 mL
Equivalent price position
No other current listing with the same generic, strength, dosage form and compatible unit basis is available for comparison.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Human papillomavirus vaccine (quadrivalent recombinant)
- Therapeutic area
- Vaccines & immunologicals
- Drug class
- Vaccines
- ATC
- J07
- Strength
- 20 mcg (HPV6) + 40 mcg (HPV11) + 40 mcg (HPV16) + 20 mcg (HPV18) / 0.5 mL
- Dosage form
- Vaccine injection
- Pack
- 1's
- Registration no.
- 052209
- Price record verified
- 2026-08-07
- Latest DRAP source check
- 2026-11-12 02:58
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →About Gardasil 20 mcg (HPV6) + 40 mcg (HPV11) + 40 mcg (HPV16) + 20 mcg (HPV18) / 0.5 mL vaccine injection
Gardasil 20 mcg (HPV6) + 40 mcg (HPV11) + 40 mcg (HPV16) + 20 mcg (HPV18) / 0.5 mL vaccine injection contains Human papillomavirus vaccine (quadrivalent recombinant) 20 mcg (HPV6) + 40 mcg (HPV11) + 40 mcg (HPV16) + 20 mcg (HPV18) / 0.5 mL. It is registered with DRAP by Searle Pakistan Limited (registration no. 052209). Its official price is PKR 17,463.36 for a pack of 1's. This price has applied since 4 August 2025. No other brand of Human papillomavirus vaccine (quadrivalent recombinant) 20 mcg (HPV6) + 40 mcg (HPV11) + 40 mcg (HPV16) + 20 mcg (HPV18) / 0.5 mL in this form is listed in Pakistan.
Other brands of Human papillomavirus vaccine (quadrivalent recombinant) 20 mcg (HPV6) + 40 mcg (HPV11) + 40 mcg (HPV16) + 20 mcg (HPV18) / 0.5 mL vaccine in Pakistan
No other brand of Human papillomavirus vaccine (quadrivalent recombinant) 20 mcg (HPV6) + 40 mcg (HPV11) + 40 mcg (HPV16) + 20 mcg (HPV18) / 0.5 mL vaccine is listed in Pakistan. See all strengths and forms of Human papillomavirus vaccine (quadrivalent recombinant) →
How old is this price? It was fixed on 4 August 2025 and has not changed since — that is 15 months ago. It is still the price the Drug Regulatory Authority of Pakistan has notified, so it remains the official maximum, but it is not a figure from this month. Please check the current position before quoting it in an article, a tender or a purchase order.
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Gardasil, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- Searle Pakistan Limited, Karachi
- DRAP registration
- 052209
- Phone
- +92 21 35822312-3; +92 21 35374436-7
- Website
- https://www.searlepakistan.com/
- Contact page
- Company contact page
Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
No change in the official DRAP price is recorded for this pack (1's). Current price PKR 17,463.36, effective 4 Aug 2025.
Cite this price history
MedInfoBase. Gardasil 20 mcg (HPV6) + 40 mcg (HPV11) + 40 mcg (HPV16) + 20 mcg (HPV18) / 0.5 mL, 1's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/gardasil-20-mcg-hpv6-40-mcg-hpv11-40-mcg-hpv16-20-mcg-hpv18-0-5-ml-052209-1s-searle-pakistan-limited/ (accessed 12 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 17,463.36 | 2025-08-04 | 2026-09-22 | DRAP PharmaPrice Index (recovered from snapshot #84) | Current |
Cite this record
Medicine record · DRAP registration 052209Price and registration data on this page were observed on 22 September 2026. Records change over time, so please cite the observation date alongside the access date.